← Dashboard
Stock
ZBH
ZIMMER BIOMET HOLDINGS, INC.Health CareHealth Care EquipmentLatest close $856 of 27 marquee funds currently hold1 CUSIP mapped
Current holders
6
27 funds tracked
Ever held
14
Current + past
New this quarter
1
Exited this quarter
2
Marquee-fund ownership over time
Aug 13, 2013Nov 14, 2017May 16, 2022May 15, 2026
Now
6
This quarter's activity
New positions opened
Current holders
Sorted by tenure (longest first)| Fund | First disclosed | Held | Entry price | Latest close | Return on entry |
|---|---|---|---|---|---|
| Bridgewater Associates re-entered | Q3 2013 | 52Q | $72 | $85 | +19% |
| Renaissance Technologies re-entered | Q3 2024(8Q snapshot) | 7Q | $106 | $85 | -20% |
| Citadel Advisors re-entered | Q3 2024(8Q snapshot) | 7Q | $107 | $85 | -20% |
| D.E. Shaw re-entered | Q3 2024(8Q snapshot) | 7Q | $107 | $85 | -20% |
| AQR Capital Management | Q3 2024(8Q snapshot) | 7Q | $107 | $85 | -20% |
| Two Sigma Investments re-entered | Q1 2025(8Q snapshot) | 5Q | $99 | $85 | -14% |
“Return on entry” is the price-only move from the fund's first disclosure to today — it ignores any adds, trims, or dividends. A fund that built its position over multiple quarters has a true cost basis somewhere between entry price and latest close; this figure is the upper bound.
Past holders
Funds that exited at some point| Fund | Last entry | Exited | Entry → Exit | Return |
|---|---|---|---|---|
| Millennium Management | Q3 2024 | Q2 2026 | → $84 | -22% |
| Point72 Asset Management 2× in & out | Q1 2026 | Q2 2026 | → $84 | -14% |
| Viking Global Investors 4× in & out | Q4 2020 | Q2 2022 | → $111 | -20% |
| Maverick Capital 2× in & out | Q3 2020 | Q2 2022 | → $111 | -13% |
| Third Point | Q3 2021 | Q1 2022 | → $109 | -20% |
| Duquesne Family Office | Q3 2020 | Q4 2020 | → $139 | +10% |
| JANA Partners | Q3 2017 | Q2 2020 | → $104 | +2% |
| Glenview Capital | Q2 2017 | Q1 2018 | → $107 | -3% |
Insider activity
Form 4 — officers, directors, 10%+ ownersFiled within two business days of each transaction by anyone with material insider status at ZIMMER BIOMET HOLDINGS, INC.. Pair with the holders table above as a sanity check: heavy insider buying alongside marquee-fund accumulation is the strongest accumulation signal; heavy insider selling alongside fund exits is the strongest distribution signal.
Filings · last 30d
12
Filings · last 90d
29
Total on file
701
Recent SEC buffer
Most recent
Jun 3, 2026
30d / 90d windows measured from Jun 3, 2026 — the most recent Form 4 on file — not from today.
- Form 40002059755-26-000006Jun 3, 2026
- Form 40001635943-26-000013Jun 2, 2026
- Form 40001485164-26-000006May 27, 2026
- Form 40001166854-26-000002May 27, 2026
- Form 40001587868-26-000008May 27, 2026
- Form 40001999146-26-000006May 27, 2026
- Form 40001910621-26-000006May 27, 2026
- Form 40001689392-26-000008May 27, 2026
- Form 40001745891-26-000004May 27, 2026
- Form 40001142083-26-000006May 27, 2026
- Form 40001222676-26-000008May 27, 2026
- Form 40001714585-26-000010May 5, 2026
- Form 40002059755-26-000004Apr 3, 2026
- Form 40001745891-26-000002Apr 2, 2026
- Form 40001689392-26-000004Apr 2, 2026
Showing 15 of 701 recent Form 4 filings. Browse all on EDGAR ↗
Fundamentals
XBRL · ZIMMER BIOMET HOLDINGS, INC.Annual figures sourced directly from ZIMMER BIOMET HOLDINGS, INC.'s 10-K / 10-Q filings via SEC EDGAR XBRL. Latest fiscal year and the year-over-year change, with up to ten years of history.
Revenue
$8.23B
FY2025+7% YoY
Net income
$705.1M
FY2025-22% YoY
EPS (diluted)
$3.55
FY2025-20% YoY
Free cash flow(?)
$1.47B
FY2025+14% YoY
Recent SEC filings
10-K · 10-Q · 8-K · 13D/G · proxyThe most recent material filings for ZIMMER BIOMET HOLDINGS, INC. — earnings, material events, ownership disclosures, proxy statements. Form 4 insider activity is shown in the panel above.
- 8-KMaterial eventMay 27, 2026
- 8-KMaterial eventMay 12, 2026
- 10-QQuarterly reportMay 1, 2026
- 8-KMaterial eventApr 28, 2026
- 8-KMaterial eventApr 28, 2026
- DEF 14AProxy statementApr 1, 2026
- 10-KAnnual reportFeb 20, 2026
- 8-KMaterial eventFeb 10, 2026
- 8-KMaterial eventJan 12, 2026
- 10-QQuarterly reportNov 5, 2025
- 8-KMaterial eventNov 5, 2025
- 8-KMaterial eventOct 7, 2025
- 8-KMaterial eventSep 4, 2025
- 10-QQuarterly reportAug 7, 2025
- 8-KMaterial eventAug 7, 2025
Trade history
Every open→close lifecycle across tracked funds| Fund | Open date | Close date | Open price | Close price / current | Return |
|---|---|---|---|---|---|
| Renaissance Technologies | Q2 2026 | open | $83 | $85 | +3% |
| D.E. Shaw | Q1 2026 | open | $97 | $85 | -12% |
| Point72 Asset Management | Q1 2026 | Q2 2026 | $97 | $84 | -14% |
| Citadel Advisors | Q4 2025 | open | $89 | $85 | -5% |
| Two Sigma Investments | Q4 2025 | open | $89 | $85 | -5% |
| Renaissance Technologies | Q4 2025 | Q1 2026 | $90 | $95 | +5% |
| Point72 Asset Management | Q2 2025 | Q3 2025 | $96 | $101 | +6% |
| Two Sigma Investments | Q1 2025 | Q3 2025 | $99 | $101 | +2% |
| Citadel Advisors | Q3 2024 | Q3 2025 | $107 | $101 | -5% |
| D.E. Shaw | Q3 2024 | Q3 2025 | $107 | $101 | -5% |
| AQR Capital Management | Q3 2024 | open | $107 | $85 | -20% |
| Millennium Management | Q3 2024 | Q2 2026 | $107 | $84 | -22% |
| Renaissance Technologies | Q3 2024 | Q1 2025 | $106 | $99 | -7% |
| Third Point | Q3 2021 | Q1 2022 | $137 | $109 | -20% |
| Viking Global Investors | Q4 2020 | Q2 2022 | $139 | $111 | -20% |
| Bridgewater Associates | Q4 2020 | open | $140 | $84 | -40% |
| Maverick Capital | Q3 2020 | Q2 2022 | $127 | $111 | -13% |
| Duquesne Family Office | Q3 2020 | Q4 2020 | $127 | $139 | +10% |
| Bridgewater Associates | Q2 2020 | Q3 2020 | $104 | $128 | +24% |
| Maverick Capital | Q3 2019 | Q4 2019 | $123 | $134 | +8% |
| Viking Global Investors | Q2 2019 | Q3 2019 | $109 | $123 | +13% |
| Viking Global Investors | Q3 2017 | Q4 2017 | $102 | $102 | -0% |
| JANA Partners | Q3 2017 | Q2 2020 | $102 | $104 | +2% |
| Glenview Capital | Q2 2017 | Q1 2018 | $110 | $107 | -3% |
| Bridgewater Associates | Q1 2017 | Q2 2017 | $106 | $109 | +3% |
| Bridgewater Associates | Q3 2015 | Q2 2016 | $93 | $105 | +14% |
| Bridgewater Associates | Q1 2015 | Q2 2015 | $103 | $101 | -2% |
| Viking Global Investors | Q3 2014 | Q4 2014 | $86 | $97 | +13% |
| Bridgewater Associates | Q3 2013 | Q2 2014 | $72 | $89 | +24% |
Caveats
- Covers only the 27 marquee funds tracked here, not the full institutional universe. A “0 holders” reading does not mean unowned.
- Heavy funds (Renaissance Technologies, Citadel Advisors, Soros Fund Management, Two Sigma Investments, D.E. Shaw, AQR Capital Management, Millennium Management, Point72 Asset Management) use 8-quarter snapshots, so their pre-2024 history is missing.
- “Current” reflects each fund's most recent 13F — filings lag the actual trade by up to 45 days; positions shown may have changed since.
- Cost = price at the entry filing date. Re-entered positions show the most recent open lot.
- Options, ADRs, and unmapped CUSIPs are excluded from the follower-backtest pipeline that produces these snapshots, so certain holding types won't appear here.